ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 123 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,724,071 | -11.7% | 1,341,907 | 0.0% | 0.51% | +1.6% |
| Q2 2023 | $3,086,386 | -49.1% | 1,341,907 | -32.9% | 0.50% | -86.6% |
| Q1 2023 | $6,060,273 | +30.0% | 2,000,090 | 0.0% | 3.76% | -41.4% |
| Q4 2022 | $4,660,210 | +22.0% | 2,000,090 | 0.0% | 6.41% | +5.9% |
| Q3 2022 | $3,820,000 | -21.7% | 2,000,090 | +11.1% | 6.05% | -22.1% |
| Q2 2022 | $4,881,000 | +5.8% | 1,801,000 | +16.4% | 7.77% | +171.6% |
| Q1 2022 | $4,612,000 | – | 1,547,739 | – | 2.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |